Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Effects of Thrombopoietin Mimetics on Patients with Chronic ITP: Perspectives from Blood Transcriptome Profiling Analysis

Haiyu Zhang, PhD, Bing Zhang, MD MS, Xiangqian Guo, PhD, Naznin Haq, B.A., Robert B West, MD PhD, James B. Bussel, MD, James L. Zehnder, MD

Blood (2014) 124 (21): 2780.

https://doi.org/10.1182/blood.V124.21.2780.2780

Published: 2014

Journal Articles

Safety and Efficacy Of Eltrombopag At Escalated Doses Up To 150mg In Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive To 75 Mg

Catherine E. McGuinn, MD, Allison Imahiyerobo, ANP- BC, Micha Thompson, B.A., Naznin Haq, B.A., Claudia Tchatchouang, M.A., James B Bussel, MD

Blood (2013) 122 (21): 3559.

https://doi.org/10.1182/blood.V122.21.3559.3559

Published: 2013

Journal Articles

The Influence Of KIR Haplotype In ITP Incidence, Treatment Response and Bleeding Symptoms

Bethan Psaila, MD, PhD, Nayla Boulad, BA, Emily Leven, Naznin Haq, B.A., Christina Soo Lee, BA, Shehzad Ahmad, Ruhena Sargent, Kate Stringaris, MD, MRCP, FRCPath, David Marin, MD, Katayoun Rezvani, MD, PhD, James B. Bussel, MD, Nichola Cooper, MD

Blood (2013) 122 (21): 2316.

https://doi.org/10.1182/blood.V122.21.2316.2316

Published: 2013

Journal Articles

Survey of the Side Effects of ITP Therapies

Charles W Shaffer, Naznin Haq, James B Bussel, MD

Blood (2012) 120 (21): 3327.

https://doi.org/10.1182/blood.V120.21.3327.3327

Published: 2012

Journal Articles

A Survey of the Etiology of Immune Thrombocytopenia (ITP).

Valerie Arias, Candidate for MD, 2014, Ehsan Shabbir, MD, Daniel Victorio, Candidate for BS, 2013, Emily Sperling, Candidate for BA, 2014, Naznin Haq, BA, James B Bussel, MD

Blood (2012) 120 (21): 2239.

https://doi.org/10.1182/blood.V120.21.2239.2239

Published: 2012

Journal Articles

CD16 + monocytes control T-cell subset development in immune thrombocytopenia

Hui Zhong, Weili Bao, Xiaojuan Li, Allison Miller, Caroline Seery, Naznin Haq, James Bussel, Karina Yazdanbakhsh

Blood (2012) 120 (16): 3326–3335.

https://doi.org/10.1182/blood-2012-06-434605

Published: 2012

Includes: Supplemental data

Journal Articles

Translational Regulation of Gene Expression by Cytoplasmic Nucleophosmin in AML: A Global Evaluation of RNA’s Differentially Recruited to Polyribosomes.

Kotaro Funato, MD, PhD, Naznin Haq, Yezhou Sun, PhD, Jin Chen, PhD, Greg Khitrov, PhD, Weijia Zhang, PhD, David W. Sternberg, MD, PhD

Blood (2007) 110 (11): 720.

https://doi.org/10.1182/blood.V110.11.720.720

Published: 2007

Journal Articles

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

Philipp B. Staber, Paul Vesely, Naznin Haq, Rene G. Ott, Kotaro Funato, Isabella Bambach, Claudia Fuchs, Silvia Schauer, Werner Linkesch, Andelko Hrzenjak, Wilhelm G. Dirks, Veronika Sexl, Helmut Bergler, Marshall E. Kadin, David W. Sternberg, Lukas Kenner, Gerald Hoefler

Blood (2007) 110 (9): 3374–3383.

https://doi.org/10.1182/blood-2007-02-071258

Published: 2007

Includes: Supplemental data

Journal Articles

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

Philipp B. Staber, MD, Paul Vesely, MS, Rene Ott, PhD, Naznin Haq, Werner Linkesch, MD, Silvia Schauer, Andelko Hrzenjak, PhD, Lukas Kenner, MD, Wilhelm Dirks, PhD, Marshall E. Kadin, MD, David W. Sternberg, MD PhD, Gerald Hoefler, MD

Blood (2006) 108 (11): 1428.

https://doi.org/10.1182/blood.V108.11.1428.1428

Published: 2006

Journal Articles

Translational Regulation of Gene Expression by the NPM-ALK Fusion Kinase of Anaplastic Large Cell Lymphoma: A Global Evaluation of Differentially Recruited mRNA’s to Polyribosomes.

Kotaro Funato, MD, PhD, Naznin Haq, Yezhou Sun, Jin Chen, Greg Khitrov, PhD, Weijia Zhang, PhD, David W. Sternberg, MD, PhD

Blood (2006) 108 (11): 291.

https://doi.org/10.1182/blood.V108.11.291.291

Published: 2006

Journal Articles

Inhibition of the NPM-ALK Fusion Tyrosine Kinase in Hematopoietic Neoplasia by the Small Molecule Tyrosine Kinase Antagonist TAE684.

David W. Sternberg, MD, PhD, Arghya Ray, PhD, Benjamin H. Lee, MD, PhD, Jennifer Adelsperger, Nicole Duclos, Elizabeth McDowell, Naznin Haq, Patricia Imbach, Osamu Ohmori, Toshiyuki Honda, Markus Warmuth, Doriano Fabbro, PhD, James D. Griffin, MD, Johannes Roesel, PhD

Blood (2006) 108 (11): 828.

https://doi.org/10.1182/blood.V108.11.828.828

Published: 2006

Journal Articles

Cell Proliferation Induced by the NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Is Mediated by mTOR/S6K1 and MEK/ERK Signaling.

Ravi K. Amaravadi, MD, Naznin Haq, Stephan W. Morris, MD, D. Gary Gilliland, PhD, MD, David W. Sternberg, MD, PhD

Blood (2004) 104 (11): 241.

https://doi.org/10.1182/blood.V104.11.241.241

Published: 2004

NARROW

Effects of Thrombopoietin Mimetics on Patients with Chronic ITP: Perspectives from Blood Transcriptome Profiling Analysis

Safety and Efficacy Of Eltrombopag At Escalated Doses Up To 150mg In Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) Not Responsive To 75 Mg

The Influence Of KIR Haplotype In ITP Incidence, Treatment Response and Bleeding Symptoms

Survey of the Side Effects of ITP Therapies

A Survey of the Etiology of Immune Thrombocytopenia (ITP).

CD16 + monocytes control T-cell subset development in immune thrombocytopenia

Translational Regulation of Gene Expression by Cytoplasmic Nucleophosmin in AML: A Global Evaluation of RNA’s Differentially Recruited to Polyribosomes.

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling

NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.

Translational Regulation of Gene Expression by the NPM-ALK Fusion Kinase of Anaplastic Large Cell Lymphoma: A Global Evaluation of Differentially Recruited mRNA’s to Polyribosomes.

Inhibition of the NPM-ALK Fusion Tyrosine Kinase in Hematopoietic Neoplasia by the Small Molecule Tyrosine Kinase Antagonist TAE684.

Cell Proliferation Induced by the NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Is Mediated by mTOR/S6K1 and MEK/ERK Signaling.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only